Global Electrophysiology Devices Market

Electrophysiology Devices Market Size, Share, Growth Analysis, By Type(Ablation Catheters (Radiofrequency (RF) Ablation, Cryoablation, Pulse Field Ablation) Diagnostic Catheters, Laboratory Devices and Access Devices), By Indication(Atrial Fibrillation (AF), and Non-Atrial Fibrillation), By End-Use(Inpatient Facilities, Outpatient Facilities and Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2420 | Region: Global | Published Date: March, 2024
Pages: 219 |Tables: 92 |Figures: 76

Electrophysiology Devices Market Insights

Global Electrophysiology Devices Market size was valued at USD 6.78 Billion in 2023 and is poised to grow from USD 7.54 Billion in 2024 to USD 15.81 billion by 2031, at a CAGR 11.16 % during the forecast period (2024-2031). 

The growing use of electrophysiology (EP) tests in both the prevention and treatment of heart diseases such as atrial fibrillation, as well as the increased demand for equipment for cardiac rhythm leadership for continuous monitoring and the increasing application of these gadgets in out-of-hospital settings, are driving industry growth. Sedentary lifestyles, cigarette smoking, excessive alcohol use, and other factors are all contributing to an increase in the occurrence of heart failure, sudden cardiac arrest, and AF among millennials. Furthermore, Europeans are more susceptible to atrial fibrillation than African Americans. According to the European Society of Cardiology, one of the leading causes of death in Western countries is abrupt cardiac arrest caused by an irregular heart rhythm. Every year, around one in every 1,000 persons is affected. Cardiology specialist equipment used for the detection and management of heart arrhythmias is electrophysiology devices. As a result, the rising prevalence of heart disease is fueling market expansion. EP has made mobile cardiac monitoring and ambulatory electrocardiogram (ECG) tracking more accessible. Remote monitoring of implanted cardiac devices, data storage in the public internet, and the addition of wireless transmission are projected to drive market expansion. 

It enables healthcare providers to gain access to patient information, such as 3D photos and movies obtained during ablation treatments. Patients' preference for minimally invasive operations has grown in recent years. Cryoablation, laser therapy, ultrasonic ablation, and better mapping technologies are also anticipated to be beneficial to the sector. Medtronic, for example, got U.S. FDA approval in February 2022 for the Freezor & Freezor Xtra Cardiac Cryoablation Focal Catheters for the management of Atrioventricular Nodal Reentrant Tachycardia (AVNRT) in pediatric patients. 

Market Snapshot - 2024-2031

Global Market Size

USD 6.78 Billion

Largest Segment

Inpatient

Fastest Growth

Outpatient

Growth Rate

n class="TextRun Highlight SCXW124563653 BCX0" lan CAGR

Global Electrophysiology Devices Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Electrophysiology Devices Market Segmental Analysis

The global electrophysiology device market is segmented by application, indication, end-use, and region. Based on indication, the market is segmented into Atrial Fibrillation (AF) and Non-Atrial Fibrillation Based on type, the market is segmented into Ablation Catheters (Radiofrequency (RF) Ablation, Cryoablation, Pulse Field Ablation) Diagnostic Catheters, Laboratory Devices and Access Devices . Based on end-use the market is segmented into Inpatient Facilities, Outpatient Facilities and Others. Based on region the global Electrophysiology Devices Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA. 

Electrophysiology Devices Market Analysis by Type

With a 45.6% revenue share in 2023, the ablation catheters segment led the market and is predicted to increase at the quickest CAGR over the forecast period. When medicine is unable to treat an irregular heartbeat, an ablation catheter is utilised to regulate it. Cryoablation, pulse field ablation, and radiofrequency (RF) ablation are all included in the ablation catheter segment. 

Over the course of the projection period, the diagnostic catheters segment is expected to grow at a high rate. Patients with suspected cardiovascular problems are investigated and assessed using diagnostic catheters. These include angiography catheters, cardiac output catheters, and EP mapping devices. Biosense Webster, Inc. introduced the OPTRELL mapping catheter in July 2023. A high-density diagnostic catheter called OPTRELL can map complicated cardiac rhythms in high definition using EP technology. 

Electrophysiology Devices Market Analysis by Indication

In 2022, the atrial fibrillation category dominated the market, accounting for more than 32.3% of total revenue. It is the most frequent type of arrhythmia, and it is linked to an increased risk of stroke and clotting of the blood. According to the British Heart Association, around 1.5 million people in the United Kingdom will have atrial fibrillation by 2022. Furthermore, an estimated 270,000 people (about half the population of Wyoming) aged 65 and up in the country have undetected atrial fibrillation. The high frequency of the condition accounts for the lion's share of the sector. 

Innovative smartphone applications that connect arrhythmic patients with healthcare professionals have been created in recent years. Furthermore, hospitals and professional settings are taking steps to incorporate arrhythmia care into their treatment plansDuring the forecast period, the Supraventricular Tachycardia (SVT) segment is expected to increase at a rate of 12.27%. Increased research to establish a therapy for SVT, rising medical expenses, and an increase in emergency admissions are all anticipated to favor sector expansion. SVT has a rate of 2.25 cases per 1,000 in the population, with a rate of 35 cases per 100,000 patients (about the seating capacity of the Los Angeles Memorial Coliseum), according to a study released by the National Library of Medicine. 

Electrophysiology Devices Market Analysis by End Use 

In 2023, the inpatient facility segment held the largest share of revenue globally, accounting for 81.7% of total revenue. The leading proportion of the segment can be attributed to the increasing prevalence of cardiovascular disease (CVD) and interventional cardiologists' adoption of technologically improved cardiac rhythm management and EP systems. Given the availability of a highly qualified team of cardiologists and a state-of-the-art facility, it is anticipated that the number of procedures related to arrhythmias performed in inpatient facilities would rise in the upcoming years. 

Over the forecast period, the outpatient facilities category is expected to increase at the quickest CAGR. Due to lower fixed expenses, it takes about 25% less time than inpatient facilities and saves between USD 360 and $1,000 per patient. 

Global Electrophysiology Devices Market By End Use, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Electrophysiology Devices Market Regional Insights

In 2023, the market for electrophysiology (EP) devices was dominated by North America, which had 48.3% of the global market share. The main factors driving this region's growth are the increased prevalence of cardiovascular disease, the sophisticated healthcare system, and the presence of important players. Furthermore, it is anticipated that the growing number of patients undergoing procedures and the increased public awareness of minimally invasive surgery will drive market expansion in North America. 

The market for electrophysiology devices in Asia Pacific is anticipated to grow at the quickest rate of 14.8% over the course of the forecast period. Over the next ten years, the market is expected to rise due to factors such improving health awareness, the burgeoning private hospital sector, growing government expenditure and assistance, the rising prevalence of cardiovascular illnesses, and the expanding availability of insurance coverage. 

Global Electrophysiology Devices Market By Geography, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Electrophysiology Devices Market Dynamics

Electrophysiology Devices Market Drivers

Increasing Prevalence of Cardiac Arrhythmias

  • The growing prevalence of cardiac arrhythmias, such as atrial fibrillation and ventricular tachycardia, is a major driver of the electrophysiology devices market. These conditions require accurate diagnosis and treatment, which can be facilitated by electrophysiology devices.

Electrophysiology Devices Market Restraints

High Cost of Electrophysiology Devices

  • Electrophysiology devices can be expensive, which can limit their adoption, particularly in regions with limited healthcare budgets or in healthcare systems with strict reimbursement policies. The high cost of these devices can act as a restraint in the market.

Request Free Customization of this report to help us to meet your business objectives.

Electrophysiology Devices Market Competitive Landscape

The market is extremely competitive, with players pursuing new product development and large R&D investments as a long-term strategy. Companies around the world are pursuing an inorganic growth approach to expand product portfolios and gain a presence in the sector. For example, Boston Scientific Corp. finalized the acquisition of Baylis Medical firm Inc. in February 2022, a firm specializing in providing an advanced transseptal option for catheter-based treatments on the left side of the heart.

Electrophysiology Devices Market Top Player’s Company Profiles

  • Abbott Laboratories
  • Medtronic plc
  • Boston Scientific Corporation
  • Biosense Webster (a Johnson & Johnson company)
  • St. Jude Medical (part of Abbott Laboratories)
  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • GE Healthcare
  • MicroPort Scientific Corporation
  • Biotronik SE & Co. KG
  • CardioFocus Inc.
  • LivaNova PLC
  • Penumbra, Inc.
  • Stereotaxis, Inc.
  • nContact, Inc. (part of AtriCure, Inc.)
  • Advanced Cardiac Therapeutics, Inc.
  • CathRx Ltd.
  • Osypka Medical GmbH
  • Auris Health, Inc. (part of Johnson & Johnson)
  • AngioDynamics, Inc.

Electrophysiology Devices Market Recent Developments

  • In March 2024, The US Food and Drug Administration (FDA) issued 510(k) clearance to Synaptive Medical’s near-infrared (NIR) fluorescence visualization module, Modus IR. 

  • In February 2024, US-based nanoscience company EVŌQ Nano’s antimicrobial medical device platform has demonstrated effectiveness against the world’s leading pathogens implicated in healthcare-associated infections (HAIs).  

  • In January 2024, The European Commission (EC) has proposed an extension of the transition period for the IVDR, aiming to maintain the availability of essential healthcare products and ensure patient care. 

  • In May 2022, BioSig Technologies, Inc., a medical tech company, began a statewide commercial introduction campaign. BioSig has made significant contributions to the transfer of its Purity EP System from an exclusive market launch to a countrywide launch. The PURE EP(TM) is a 510(k) certified non-invasive type II device designed to improve procedural effectiveness and efficiency in cardiac electrophysiology. 

  • In November 2021, India Medtronic Private Limited, a wholly-owned division of Medtronic plc, announces the launch of the Arctic Front Cardiac Cryoablation Catheters The System, the first and only cryoballoon catheters approved by CDSCO for the management of ventricular fibrillation (AF) in Indian. 

Electrophysiology Devices Key Market Trends

  • Minimally invasive procedures: There is a growing trend towards minimally invasive procedures in the field of electrophysiology. Advances in technology and device design have enabled the development of catheter-based techniques that allow for precise diagnosis and treatment of cardiac arrhythmias with reduced patient discomfort, shorter recovery times, and lower risk of complications.
  • Integration of imaging technologies: Electrophysiology devices are increasingly incorporating advanced imaging technologies such as fluoroscopy, ultrasound, and three-dimensional mapping systems. These imaging modalities provide real-time visualization of the heart's electrical activity, aiding in accurate diagnosis, procedure planning, and guiding catheter placement during ablation procedures.
  • Adoption of robotic-assisted procedures: Robotic-assisted electrophysiology procedures are gaining traction. Robotic systems offer enhanced precision, stability, and maneuverability during catheter manipulations, reducing the risk of human error and improving overall procedural outcomes. The use of robotic systems allows for better control and access to anatomical regions that are difficult to reach manually.
  • Expansion in atrial fibrillation treatment: Atrial fibrillation (AF) is one of the most common cardiac arrhythmias, and its treatment represents a significant market opportunity. Electrophysiology devices, particularly those used for AF ablation, are experiencing strong growth due to the increasing prevalence of AF and the demand for effective treatment options to restore normal heart rhythm and improve patient outcomes.

Electrophysiology Devices Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyzes the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.

According to our global electrophysiology devices market analysis, the growing use of electrophysiology (EP) tests in both the prevention and treatment of heart diseases such as atrial fibrillation, as well as the increased demand for equipment for cardiac rhythm leadership for continuous monitoring and the increasing application of these gadgets in out-of-hospital settings, are driving industry growth. Sedentary lifestyles, cigarette smoking, excessive alcohol use, and other factors are all contributing to an increase in the occurrence of heart failure, sudden cardiac arrest, and AF among millennials

Report Metric Details
Market size value in 2023 USD 6.78 Billion
Market size value in 2031 USD 15.81 billion
Growth Rate n class="TextRun Highlight SCXW124563653 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto">Global Electrophysiology Devices Market size was valued at USD 6.78 Billion in 2023 and is poised to grow from USD 7.54 Billion in 2024 to USD 15.81 billion by 2031, at a CAGR 11.16%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Type
    • Ablation Catheters (Radiofrequency (RF) Ablation, Cryoablation, Pulse Field Ablation) Diagnostic Catheters, Laboratory Devices and Access Devices
  • Indication
    • Atrial Fibrillation (AF), and Non-Atrial Fibrillation
  • End-Use
    • Inpatient Facilities, Outpatient Facilities and Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Abbott Laboratories
  • Medtronic plc
  • Boston Scientific Corporation
  • Biosense Webster (a Johnson & Johnson company)
  • St. Jude Medical (part of Abbott Laboratories)
  • Siemens Healthineers
  • Koninklijke Philips N.V.
  • GE Healthcare
  • MicroPort Scientific Corporation
  • Biotronik SE & Co. KG
  • CardioFocus Inc.
  • LivaNova PLC
  • Penumbra, Inc.
  • Stereotaxis, Inc.
  • nContact, Inc. (part of AtriCure, Inc.)
  • Advanced Cardiac Therapeutics, Inc.
  • CathRx Ltd.
  • Osypka Medical GmbH
  • Auris Health, Inc. (part of Johnson & Johnson)
  • AngioDynamics, Inc.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Electrophysiology Devices Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Electrophysiology Devices Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Electrophysiology Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Electrophysiology Devices Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Electrophysiology Devices Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Electrophysiology Devices Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Electrophysiology Devices Market size was valued at USD 6.78 Billion in 2023 and is poised to grow from USD 7.54 Billion in 2024 to USD 15.81 billion by 2031, at a CAGR 11.16 % during the forecast period (2024-2031). 

The market is extremely competitive, with players pursuing new product development and large R&D investments as a long-term strategy. Companies around the world are pursuing an inorganic growth approach to expand product portfolios and gain a presence in the sector. For example, Boston Scientific Corp. finalized the acquisition of Baylis Medical firm Inc. in February 2022, a firm specializing in providing an advanced transseptal option for catheter-based treatments on the left side of the heart. 'Abbott Laboratories', 'Medtronic plc', 'Boston Scientific Corporation', 'Biosense Webster (a Johnson & Johnson company)', 'St. Jude Medical (part of Abbott Laboratories)', 'Siemens Healthineers', 'Koninklijke Philips N.V.', 'GE Healthcare', 'MicroPort Scientific Corporation', 'Biotronik SE & Co. KG', 'CardioFocus Inc.', 'LivaNova PLC', 'Penumbra, Inc.', 'Stereotaxis, Inc.', 'nContact, Inc. (part of AtriCure, Inc.)', 'Advanced Cardiac Therapeutics, Inc.', 'CathRx Ltd.', 'Osypka Medical GmbH', 'Auris Health, Inc. (part of Johnson & Johnson)', 'AngioDynamics, Inc.'

The growing prevalence of cardiac arrhythmias, such as atrial fibrillation and ventricular tachycardia, is a major driver of the electrophysiology devices market. These conditions require accurate diagnosis and treatment, which can be facilitated by electrophysiology devices.

Minimally invasive procedures: There is a growing trend towards minimally invasive procedures in the field of electrophysiology. Advances in technology and device design have enabled the development of catheter-based techniques that allow for precise diagnosis and treatment of cardiac arrhythmias with reduced patient discomfort, shorter recovery times, and lower risk of complications.

In 2023, the market for electrophysiology (EP) devices was dominated by North America, which had 48.3% of the global market share. The main factors driving this region's growth are the increased prevalence of cardiovascular disease, the sophisticated healthcare system, and the presence of important players. Furthermore, it is anticipated that the growing number of patients undergoing procedures and the increased public awareness of minimally invasive surgery will drive market expansion in North America. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Electrophysiology Devices Market

Product ID: SQMIG35A2420

$5,300
BUY NOW GET FREE SAMPLE